Form D · Pharmaceuticals
Adheron Therapeutics, Inc.
Berkeley, CA · CIK 0001649103
Offering snapshot reported Jul 31, 2015 · SEC filing
- Reported sold
- $1.5M Offering amount: $1.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 17, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2015 | Initial | $1,500,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-244897
Convertible Promissory Notes, convertible into shares of common stock or preferred stock, as the case may be. Warrants are issuable immediately prior to an equity financing, exercisable for the same class of shares as sold in such equity financing.
Source: Form D, filed Jul 31, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bob Baltera | Director, Executive |
| David Castaldi | Director |
| Rajeev Dadoo | Director |
| Hari Kumar | Director, Executive |
| Ron Laufer | Director |
| Doug Onsi | Director |
| Isai Peimer | Director |
| Chris Thomajan | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Mail Boxes Plus, Box 104 2930 Domingo Avenue
Berkeley, CA, 94705
Berkeley, CA, 94705